Charles Schwab
IFRX icon

Charles Schwab’s InflaRx IFRX Stock Holding History

Charles Schwab’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-46,310
Closed -$1.59M – 3149
2018
Q3 		$1.59M Buy
46,310
+29,394
+174% +$948K ﹤0.01% 2493
2018
Q2 		$546K Buy
16,916
+4,214
+33% +$146K ﹤0.01% 2779
2018
Q1 		$367K Buy
+12,702
New +$335K ﹤0.01% 2814

Other funds holding IFRX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Charles Schwab's IFRX Position: Q4 2018 in Review

Charles Schwab sold out of InflaRx (IFRX) in Q4 2018, closing a stake of 46,310 shares — an estimated $1.59M sold.

Charles Schwab first reported a position in IFRX in Q1 2018 and held it in 3 quarters. The position peaked at $1.59M in Q3 2018. 34 funds tracked by Wall St. Rank hold IFRX as of Q4 2018.

  • Charles Schwab reported no remaining InflaRx position as of Q4 2018 after selling out during the quarter.
  • Charles Schwab sold 46,310 InflaRx shares in Q4 2018, an estimated $1.59M.
  • Charles Schwab first reported a position in InflaRx in Q1 2018 and held it in 3 quarters.
  • Charles Schwab's InflaRx position peaked at $1.59M in Q3 2018.
  • 34 funds tracked by Wall St. Rank held InflaRx as of Q4 2018.

Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.